First Time Loading...

Star Combo Pharma Ltd
ASX:S66

Watchlist Manager
Star Combo Pharma Ltd Logo
Star Combo Pharma Ltd
ASX:S66
Watchlist
Price: 0.145 AUD Market Closed
Updated: May 10, 2024

Intrinsic Value

S66 doesn't have a meaningful market cap.
S66's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Star Combo Pharma Ltd. engages in the manufacture and distribution of vitamis, dietary supplements, and skincare products. [ Read More ]

The intrinsic value of one S66 stock under the Base Case scenario is 0.127 AUD. Compared to the current market price of 0.145 AUD, Star Combo Pharma Ltd is Overvalued by 13%.

Key Points:
S66 Intrinsic Value
Base Case
0.127 AUD
Overvaluation 13%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Star Combo Pharma Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling S66 stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Star Combo Pharma Ltd

Provide an overview of the primary business activities
of Star Combo Pharma Ltd.

What unique competitive advantages
does Star Combo Pharma Ltd hold over its rivals?

What risks and challenges
does Star Combo Pharma Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Star Combo Pharma Ltd.

Provide P/S
for Star Combo Pharma Ltd.

Provide P/E
for Star Combo Pharma Ltd.

Provide P/OCF
for Star Combo Pharma Ltd.

Provide P/FCFE
for Star Combo Pharma Ltd.

Provide P/B
for Star Combo Pharma Ltd.

Provide EV/S
for Star Combo Pharma Ltd.

Provide EV/GP
for Star Combo Pharma Ltd.

Provide EV/EBITDA
for Star Combo Pharma Ltd.

Provide EV/EBIT
for Star Combo Pharma Ltd.

Provide EV/OCF
for Star Combo Pharma Ltd.

Provide EV/FCFF
for Star Combo Pharma Ltd.

Provide EV/IC
for Star Combo Pharma Ltd.

Compare the intrinsic valuations
of Star Combo Pharma Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Star Combo Pharma Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Star Combo Pharma Ltd compared to its peers.

Compare the P/E ratios
of Star Combo Pharma Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Star Combo Pharma Ltd with its peers.

Analyze the financial leverage
of Star Combo Pharma Ltd compared to its main competitors.

Show all profitability ratios
for Star Combo Pharma Ltd.

Provide ROE
for Star Combo Pharma Ltd.

Provide ROA
for Star Combo Pharma Ltd.

Provide ROIC
for Star Combo Pharma Ltd.

Provide ROCE
for Star Combo Pharma Ltd.

Provide Gross Margin
for Star Combo Pharma Ltd.

Provide Operating Margin
for Star Combo Pharma Ltd.

Provide Net Margin
for Star Combo Pharma Ltd.

Provide FCF Margin
for Star Combo Pharma Ltd.

Show all solvency ratios
for Star Combo Pharma Ltd.

Provide D/E Ratio
for Star Combo Pharma Ltd.

Provide D/A Ratio
for Star Combo Pharma Ltd.

Provide Interest Coverage Ratio
for Star Combo Pharma Ltd.

Provide Altman Z-Score Ratio
for Star Combo Pharma Ltd.

Provide Quick Ratio
for Star Combo Pharma Ltd.

Provide Current Ratio
for Star Combo Pharma Ltd.

Provide Cash Ratio
for Star Combo Pharma Ltd.

What is the historical Revenue growth
over the last 5 years for Star Combo Pharma Ltd?

What is the historical Net Income growth
over the last 5 years for Star Combo Pharma Ltd?

What is the current Free Cash Flow
of Star Combo Pharma Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Star Combo Pharma Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Star Combo Pharma Ltd

Current Assets 16.6m
Cash & Short-Term Investments 9.2m
Receivables 3.3m
Other Current Assets 4.2m
Non-Current Assets 24.3m
PP&E 22.9m
Intangibles 683.6k
Other Non-Current Assets 728.9k
Current Liabilities 2.9m
Accounts Payable 2.4m
Accrued Liabilities 334k
Other Current Liabilities 188.3k
Non-Current Liabilities 4.7m
Long-Term Debt 4m
Other Non-Current Liabilities 749.8k
Efficiency

Earnings Waterfall
Star Combo Pharma Ltd

Revenue
25.7m AUD
Cost of Revenue
-19.9m AUD
Gross Profit
5.8m AUD
Operating Expenses
-4.4m AUD
Operating Income
1.4m AUD
Other Expenses
-905.1k AUD
Net Income
485.2k AUD

Free Cash Flow Analysis
Star Combo Pharma Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

S66 Profitability Score
Profitability Due Diligence

Star Combo Pharma Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

ROIC is Increasing
Positive Gross Profit
Positive 1-Year Revenue Growth
Declining ROE
31/100
Profitability
Score

Star Combo Pharma Ltd's profitability score is 31/100. The higher the profitability score, the more profitable the company is.

S66 Solvency Score
Solvency Due Diligence

Star Combo Pharma Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Negative Net Debt
56/100
Solvency
Score

Star Combo Pharma Ltd's solvency score is 56/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

S66 Price Targets Summary
Star Combo Pharma Ltd

There are no price targets for S66.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

S66 Price
Star Combo Pharma Ltd

1M 1M
+21%
6M 6M
+12%
1Y 1Y
+21%
3Y 3Y
-42%
5Y 5Y
-79%
10Y 10Y
-82%
Annual Price Range
0.145
52w Low
0.09
52w High
0.155
Price Metrics
Average Annual Return -31.01%
Standard Deviation of Annual Returns 7.77%
Max Drawdown -89%
Shares Statistics
Market Capitalization 19.6m AUD
Shares Outstanding 135 003 000
Percentage of Shares Shorted
N/A

S66 Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Star Combo Pharma Ltd Logo
Star Combo Pharma Ltd

Country

Australia

Industry

Consumer products

Market Cap

19.6m AUD

Dividend Yield

0%

Description

Star Combo Pharma Ltd. engages in the manufacture and distribution of vitamis, dietary supplements, and skincare products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2018-05-16. The firm develops, manufactures, and distributes a range of branded vitamins, dietary supplements, and skincare products, serving both domestic and offshore markets. The firm operates through two segments: Star Combo business and Austoyou retail. Star Combo business segment includes developing, manufacturing, marketing and sales of natural health supplements and skin care products. Austoyou retail business made up of the Australia-China e-commerce platform that offers products directly to Chinese health product consumers; and Koala Mall’s two retail stores in Sydney. Its products include Costar NMN, Costar osteo comples Gluco, Living Healthy and Little, Amax Top Marine Collagen E ,J&K Ultra nourishing colla and J&K Rose Oil Lanolin Cream. The company also provides Original Equipment Manufacturer (OEM) Services and Quality Assurance.

Contact

NEW SOUTH WALES
Sydney
Smithfield, 171 - 177 Woodpark Road
+61297566555.0
http://www.starcombo.com.au/

IPO

2018-05-16

Employees

-

Officers

CEO & Executive Director
Ms. Su Zhang M.B.A.
Founder, MD & Director
Mr. JinXing Zhang B.S.
Chief Financial Officer
Mr. James Ni
Chief Operating Officer
Mr. He Ben B.S.
Company Secretary
Mr. Patrick James Raper F.A.C.I.D., FAICD, FCPA

See Also

Discover More
What is the Intrinsic Value of one S66 stock?

The intrinsic value of one S66 stock under the Base Case scenario is 0.127 AUD.

Is S66 stock undervalued or overvalued?

Compared to the current market price of 0.145 AUD, Star Combo Pharma Ltd is Overvalued by 13%.